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Mammalian  pregnancy  is  a  unique  immunological  paradox  because  the  fetus, 
which  bears  paternal  histocompatible  antigens  which  are  alien  to  the  maternal 
immune system can survive normally as an allograft in the mother. Several mecha- 
nisms have been proposed to explain fetal acceptance including nonspecific suppres- 
sion  of  maternal  immunity  (1).  Previous  studies  have  suggested  that  factors  in 
pregnant sera play a  role in the suppression of maternal immunity (2-9), including 
sex hormones (2,  3), serum-blocking antibody (4), pregnancy-associated proteins (5), 
a-fetoprotein (6,  7), and as yet undefined factors. However, none of these have been 
established  as  a  major  factor  in  the  suppressed  maternal  immunity.  Moreover, 
contradictory  results  have been  recently reported  by Smith  (8)  and  Hamilton  and 
Hellstr/Sm (9), who claim that sera from syngeneically or allogeneically pregnant mice 
do not  inhibit  the responses of normal lymphocytes to alloantigens.  The reasons for 
these discrepancies are unclear.  Other evidence which suggests suppressed maternal 
immunity  during  pregnancy  includes  depressed  mixed  lymphocyte reactions  (10), 
diminished mitogen responses (6,  11), decreased leukocyte migration (12), and delayed 
skin  graft  rejection  (13).  An  increased  frequent  occurrence of severe viral infection 
during pregnancy (14)  has also been postulated to be related to suppressed maternal 
immunity.  There  have,  however, been  very few  reports  investigating  the  antibody 
response  following challenge  in  pregnant  animals.  One study  (15)  reports that  the 
circulating antibody titers to several antigens including sheep erythrocytes (SRBC) t 
were not significantly altered during pregnancy while we have previously reported a 
decreased splenic plaque-forming-cell (PFC) response following in vivo immunization 
of pregnant mice (7). 
The  present  study shows  that  in  vitro  IgM  antibody  synthesis  against  SRBC  is 
decreased  in  the  pregnant  spleen  cells  compared  to  controls,  and  moreover  this 
appears to be mediated by nonspecific splenic suppressor cells. At least two populations 
of pregnant spleen cells were shown to exert a  nonspecific suppressor effect. One is a 
T  lymphocyte and the other a nylon wool-adherent cell present in the B-cell-enriched 
macrophage-depleted fraction. Pregnant spleen cells cultured in vitro secrete soluble 
supernate factors which decrease the primary IgM antibody response of normal spleen 
cells.  We were unable  to demonstrate suppressor cells in  the pregnant  lymph node 
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cells of cervical, axillary, and popliteal regions. Finally, mitogen- and antigen-induced 
lymph node cell proliferative responses  including those  lymph nodes  draining the 
uterus, were not significantly different in pregnant and control animals. 
Materials and Methods 
Animals.  CBA/J mice were purchased from The Jackson Laboratory, Bar Harbor, Maine, 
and BALB/c mice from Cumberland View Farm, Clinton, Tenn. Pregnant CBA/J mice were 
obtained by mating CBA/J female mice to CBA/J male mice (syngeneically  pregnant), and to 
BALB/c male mice (allogeneically  pregnant) in our animal facility. The time of pregnancy was 
determined by examination of vaginal plugs. 
In Vivo  Antibody Synthesis.  Approximately 10- to 13-d pregnant CBA/J mice and age-matched 
CBA/J female mice were used. 5 X  10  s SRBC were injected i.p. 4 d later spleens were removed 
and the primary IgM antibody responses  against SRBC were studied using Jerne's hemolytic 
plaque assay as modified by Cunningham and Szenberg (16). 
To study the antibody responses  of lymph node cells,  10  ×  10  v SRBC were injected into 
both footpads of control or pregnant mice. 4 d later the popliteal lymph nodes were removed 
and the PFC assay performed. The assay was done on individual mice, and the mean and SE 
obtained. 
In  Vitro Antibody Response.  Approximately 15-d pregnant and age-matched control CBA/J 
female  mice  were  employed  for  the  in vitro  antibody responses  and  the  mitogen-induced 
proliferative responses.  10 ×  106 spleen cells were cultured with 10 ×  10  ~ SRBC in a Marbrook 
chamber for 4 d at 37°C in a humidified atmosphere of 5% COs and 95% air. Culture media 
consisted of RPMI-1640 supplemented with 5% heat-inactivated fetal calf serum (FCS)  and 
horse serum, 5 ×  10  -6 M 2-mercaptoethanol, 100 U/ml of penicillin, 100/~g/ml of streptomycin, 
and 2 mM glutamine (all supplements from Grand Island Biological Co., Grand Island, N.Y.). 
The cultures were performed on lymph node and spleen cells from individual mice or on pools 
of 4-5 mice. The mean numbers of PFC per culture were calculated from the result of triplicate 
cultures. 
Mitogen-mduced Blastogenesis.  2 ×  10  n spleen cells or lymph node cells were placed into each 
well of a  fiat-bottomed microtiter plate (No.  3042, Falcon Plastics, Div. of Becton, Dickinson 
& Co., Oxnard, Calif.) and were routinely cultured in the presence of an optimal dose (4.0/zg/ 
ml) of phytohemagglutinin (PHA; The Wellcome Research Laboratories, Beckenham, Kent, 
England), or 50/~g/ml of Escherichia coli, lipopolysaccharide (LPS; Difco Laboratories, Detroit, 
Mich.). However, various doses of PHA (1, 2, 4, and 8 p.g/mt)  and LPS (10, 20, 50, and 100 
#g/ml)  have also been employed to be certain that  there was  no shift in the dose  response 
curve.  The  culture media consisted of the  same  components as  indicated for  the  in vitro 
antibody response except that the serum supplement was 5% heat-inactivated FCS. The cultures 
were maintained at 37°C for 3 d  in a  humidified atmosphere of 5% CO2 and 95% air.  t6 h 
before harvesting, 1 /tCi of [3H]methyl thymidine in 20 pl of RPMI-1640 was added to each 
well. The cells were harvested on a glass fiber paper using a Mash II harvester (Microbiological 
Associates, Walkersville, Md.) and dissolved in 2 ml of Aquasol (New England Nuclear, Boston, 
Mass.). The radioactivity was then determined using a Beckman scintillation  counter (Beckman 
Instruments, Fullerton, Calif.). All determinations were performed in triplicate and the data is 
expressed  as the mean cpm  +-- SE. 
Antigen-induced Lymph Node Cell Proliferation.  Antigen-induced  lymph node cell (LNC) prolif- 
erative assay was  performed  using a  modification of the  method  described by Alkan (17). 
Briefly,  100/Lg of ovalbumin (OVA; Sigma Chemical Co., St. Louis, Mo.) emulsified in H37Ra 
complete adjuvant (Difco Labs) was injected into -10- to 12-d pregnant CBA/J mice and age- 
matched control mice at three different sites:  anterior and posterior footpads, and s.c. in the 
base of the tail. 7 d later draining lymph nodes of these three immunization  sites were separately 
obtained from  axillary, popliteal, and  para-aortic  (uterus-draining) regions,  and  4  ×  l0  s 
sensitized LNCs from each region were cultured in vitro with either 250 pg/ml of OVA or 50 
pg/ml of purified protein derivative (PPD; Connaught Laboratories, Toronto, Canada). 4 d 
later DNA synthesis was measured as described in mitogen-induced  blastogenesis. 
Cell Preparation.  Single cell suspensions of spleen and lymph node cells were prepared by 
gentle teasing and passing the cells through a screen mesh.  After being washed twice in cold 900  IMMUNE  RESPONSES  DURING PREGNANCY 
Hank's balanced salt solution  (BSS), the cells were resuspended in  culture media.  In some 
experiments erythrocytes contained in spleens were lysed using ammonium-chloride-potassium 
lysing buffer.  Nylon-wool-nonadherent  T  lymphocytes isolated  from  spleens  (subsequently 
referred to as spleen T cells) were obtained by the method described by Julius et al. (18). Nylon- 
wool-adherent cells were obtained using a modification of the method described by Handwerger 
and Schwartz (19).  Briefly, after nonadherent T  cells were eluted, the nylon wool column was 
washed with warm culture media. The nylon wool was then compressed with a  plunger and 
flushed with cold culture media. This process was repeated three to four times and the cells 
resuspended in culture media. Splenic macrophages were obtained as follows: 10  ×  107 spleen 
cells in 10 ml culture media were plated on 100  ×  20-mm plastic Petri dishes (Falcon Plastics) 
and incubated for 2 h at 37°C. The nonadherent cells were removed, the plates washed with 
media, and the cells adherent to the dishes were then dislodged by vigorous pipettings using 
Ca++-free Hank's BSS containing 0.02%  EDTA. The cells were washed three times before use. 
The recovered adherent cell population showed >95% viability by trypan blue exclusion, and 
contained predominantly macrophages (85-90% as determined by latex ingestion or esterase 
staining). 
Pretreatment with anti-Thy  1.2 serum plus complement was done as follows: ~50  ×  106 
cells were incubated with a  1:20 dilution of anti-Thy 1.2 serum (AKR anti-C3H thymocyte, 
purchased from Bionetics Laboratory Products, Litton Bionetics Inc., Kensington, Md.) for 30 
min at room temperature. The cells were washed once and resuspended in a  1:10 dilution of 
guinea pig complement. After incubation at 37°C for 45 min, the cells were washed three times. 
PHA- and LPS-induced blastogenesis was used to assess the effectiveness of this treatment. All 
preparations showed a  marked diminution of the PHA response and essentially no change in 
the LPS response. 
Results 
In  Vivo and In  Vitro Responses of Pregnant vs.  Age-matched Control Mice.  As shown  in 
Table I, a  significant decrease of the primary IgM antibody response in vivo against 
SRBC was observed in the pregnant spleen cells, compared to that of the age-matched 
controls. However, there was no difference in the in vivo response of lymph node cells 
between  the pregnant  and control groups.  Table II shows the results of the in  vitro 
primary IgM antibody responses. The PFC response of the pregnant spleen cells were 
two  to three times less than  those of controls.  Similar decreases were obtained with 
both syngeneically and  allogeneically pregnant  spleen cells and  also in the cultures 
stimulated with various doses of SRBC  (data not shown). The PFC responses in vitro 
of the lymph node cells from cervical, axillary, and popliteal regions were essentially 
identical in pregnant  and control animals; this experiment was repeated three times 
with essentially identical results. 
Table III shows the results of the mitogen-induced blastogenesis of spleen cells and 
lymph node  cells including those of draining lymph nodes  of the uterus.  The  data 
shows that there was no significant difference between the two groups of mice. Similar 
results were obtained when various concentrations of mitogens as well as different cell 
densities in the culture were employed (data not shown). 
Table IV demonstrates that ovalbumin and PPD-induced  lymph node cell prolif- 
eration are not significantly altered in pregnant animals. 
Is the Low PFC Response of the Pregnant Spleen Cells a Result of Suppressor Cells?  The 
experiment shown in Fig. 1 was performed in an attempt to determine whether or not 
suppressor cells were involved in the decreased PFC response of the pregnant  spleen 
cells. Various numbers  of spleen cells from  ~15-d pregnant  or age-matched control 
mice were added to the normal spleen cell culture containing 10  ×  10  n normal spleen 
cells/chamber, and the mixture cultured with  10  ×  10  n SRBC  for 4  d. As shown in KOJI  SUZUKI AND T.  B.  TOMASI, Jr. 
TABLE  [ 
Primary In  Vivo IgM Response 
901 
PFC/1  ×  106 cells 
Cell 
Control mice  Pregnant mice 
mean ± SE 
Spleen  1,206 ±  151  (9)  635  ±  80 (18)* 
Lymph node  146  ±  15 (4)  178  ±  19 (4)~ 
Pregnant (syngeneically) CBA/J mice and age-matched control CBA/J female mice 
were immunized  i.p.  with  5  ×  108 SRBC and  4  d  later direct  IgM  PFC assay 
performed on spleen cells. For direct IgM responses of lymph node cells,  10  ×  107 
SRBC were  injected into both  footpads,  and  4  d  later PFC assay  performed on 
popliteal lymph node cells. The assay was performed on individual mice and the 
mean value obtained. The number in parentheses  represents  the number of mice 
studied. 
* P< 0.01 compared to control mice. 
:~ No significant  difference observed. 
TABLE  II 
Primary In  Vitro IgM Response 
SRBC in  Cell  culture 
PFC/cuhure 
Control mice  Pregnant mice 
mean ± SE 
Spleen  +  2,412 +  238 (4)  948  ±  106 (4)* 
-  151  ztz  13  62  ±  11 
l,ymph node  +  1,210 ±  104 (3)  1,320 ±  134 (3)~ 
-  58  ±  7  64  ±  10 
10  ×  106 cells were cultured with  10  ×  l0  s SRBC in a Marbrook chamber and 4 
d later direct IgM PFC assay performed. The cultures were done on individual mice 
and the mean value of PFC response obtained. The number in parentheses  represents 
the number of mice studied. 
* P  =  0.01 compared to control mice. 
No significant  difference observed. 
Fig.  1,  the  addition  of pregnant  spleen  cells  suppressed  the  PFC  responses  of the 
normal spleen cells. Cell viability studies using trypan blue exclusion showed that  the 
pregnant  spleen cells were not cytotoxic to the normal spleen cells. The data suggests 
that  suppressor  cell  activities  are  evident  in  the  spleen  cell  population  of pregnant 
mice. No suppressor cells were observed in the lymph node cell population  (of cervical, 
axillary, and  popliteal regions). 
Suppressor  Cell Activity of Subpopulations  of Pregnant Spleen Cells.  To further character- 
ize the suppressor cells in the pregnant  spleen, the cells from pregnant  or control mice 
were  passed  over a  nylon  wool  column.  An  aliquot  of the  nylon-wool-nonadherent 
cells  (T-cell-enriched  population)  was  treated  with  anti-Thy  1.2  serum  plus comple- 
ment, and  resuspended  in the volume ofcuhure  media  required  to give a  10  X  106/ 
ml cell concentration  for the T  cells with  no  anti-Thy  1.2  serum  treatment.  1 ml of 
the  cell solution  of either  anti-Thy  1.2  treated  or nontreated  nylon-wool-purified  T 
cells were added to the normal spleen cell culture containing  10  ×  106 cells/chamber. 
As shown in Table IV, the pregnant  spleen T  cells before treatment  with anti-Thy  1.2 
serum  are  suppressive  to  the  PFC  responses  of the  normal  spleen  cell cultures  and 
suppression  was  significantly  reduced  by  the  anti-Thy  1.2  serum  plus  complement 902  IMMUNE  RESPONSES  DURING  PREGNANCY 
TABLE  III 
Mitogen-induced Blastogenesis of Lymphocytes  from Pregnant and Age-matched Control Mice 
Source of cells  Mitogen 
[nHITdR uptake 
Control mice  Pregnant mice 
~g/ml  cpm ×  10  -~ ± SE 
Spleen  --  9.2  :t: 0.4  12.6 4-  1.8 
PHA 4.0  124.9 4- 5.9  157.2 4- 9.5 
LPS 50  75.8 4- 3.5  80.9 ±  6.2 
Lymph nodes cervical and axil-  --  1.6 ±  0.3  2.0  +  0.3 
lary  PHA 4.0  121.8 4- 9.2  126.8 ±  12.6 
LPS 50  49.6 4- 4.0  42.3  4- 4.0 
Lymph  nodes  draining  uterus  --  2.4  ±  0.6  3.4  4- 0.2 
(para-aortic)  PHA 4.0  108.2 4-  12.2  116,2 4- 8.4 
LPS 50  39.7  4- 2.2  43.5  ±  1.9 
The assay was performed on individual mice and the mean value obtained from four mice of each group, 
TABLE  IV 
Antigen-induced Proliferation of LNC  from  Various Regions in Pregnant and Age-matched Control CBA /J 
Mice 
Source of sensitized 
LNC  Antigen 
[SH]TdR uptake* 
Control  Pregnant 
Axillary LNC 
Popliteal LNC 
Para-aortic  LNC  (uterus 
draining) 
ttg/ml 
--  4,907  +  1,102  4,626  +  320 
OVA 250  51,735  4- 8412  44,057  ±  6,238 
PPD 50  56,724  +  10,004  67,719  4- 9,442 
--  4,500  4-  359  5,354  4-  182 
OVA 250  53,626  ±  2,236  49,720  ±  4,018 
PPD 50  50,378  +  6,328  60,561  4-  7,124 
--  4,879  ±  306  4,359  ±  384 
OVA 250  39,702  ±  2,032  32,920  +  4,012 
PPD 50  50,306  4- 6,340  44,180  4- 6,002 
Immunization and the subsequent in vitro culture were performed on individual mice 
Materials and Methods. 
* Values represent the mean 4- SE of three mice of each group. 
as described in 
treatment  (Table  V, exp.  B).  However,  this treatment  did  not  completely  eliminate 
suppression because the PFC  responses of the cultures to which  anti-Thy  1.2-treated 
spleen T  cells of pregnant  mice were added  were still less than those of the correspond- 
ing control cultures. The  nylon-wool-adherent  spleen cells of pregnant  mice were also 
suppressive  to  the  normal  spleen  cell cultures  and  suppression  was  not  significantly 
altered by treatment  with anti-Thy  1.2 serum plus complement  (Table V, exp. C). In 
other  experiments  macrophages  were  depleted  by  adherence  to  Petri  dishes  before 
cells were  applied  to  a  nylon wool  column.  Nonadherent  cells were  then  applied  to 
the nylon wool column.  Note in Table  V, exp. D  that the pregnant  cells nonadherent 
to  Petri  dishes  are suppressive.  The  nylon-wool-adherent  cells  (B-cell-enriched mac- 
rophage-depleted  fraction) contained  80-85% surface immunoglobulin  as determined 
by  fluorescein  isothiocyanate  (FITC)  anti-mouse  kappa  antibody  and  <1%  macro- 
phages by latex ingestion or esterase staining. The  data  (Table V, exp.  E)  shows that KOJI  SUZUKI  AND  T.  B.  TOMASI, 
~  a 
~  nt 
~  2 
Jr. 
I  I  I 
2.5  5  10 x 10  6 
Spleen cells added  to 10 x 10  6 
normal spleen cells/culture 
Fro.  1.  Pregnant spleen cells suppress the PFC response of normal spleen cells. Various numbers 
of either pregnant  (×)  or control  (O)  spleen cells were added to the culture containing  10  X  106 
normal spleen cells, and the mixture cultured with  10  X  106 SRBC and 4 d  later direct IgM PFC 
assay performed. Horizontal lines represent PFC responses of 10  ×  106 normal spleen cells (solid 
line) and 10  X  106 pregnant spleen cells (dotted line). 
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TABLE  V 
Suppression of the Normal PFC Responses by Subpopulations of Pregnant Spleen Cells 
Experiment 
group 
Cells added to normal cultures 
Source of treated cells added to normal 
spleen cell cultures 
Control mice*  Pregnant mice* 
A  No treatment 
B  Nonadherent to nylon wool 
No anti-Thy 1.2 treatment 
Nonadherent to nylon wool§ 
Anti-Thy 1.2 treatment 
C  Nylon wool adherent 
No anti-Thy 1.2 treatment 
Nylon wool adherent§ 
Anti-Thy 1.2 treatment 
D  Nonadherent to Petri dishes 
E  Nonadherent to Petri dish 
Adherent  to  nylon  wool  (B-cell  en- 
riched) 
F  Adherent to Petri dishll (macrophage 
enriched) 
PFC/culture ± SE 
5,934  +  390  2,484  +__. 138 (58):~ 
5,336  +  240  3,098  +  119 (42) 
5,200  ±  380  4,624  ±  380 (12) 
6,854  +  386  2,186  +  690 (69) 
6,528  +  420  2,300  +  204 (65) 
5,355  ±  362  2,520  ±  198  (54) 
6,486  +  363  2,012  ±  55  (70) 
6,992  __  376  7,344  +  386 (--) 
* 10  X  L0  n treated cells added to cuhures containing 10  x  106 normal spieen cells. 
:~ Figures in parentheses indicate percent suppression, compared to the correspnding control PFC responses. 
PFC (control cells added)  -  PFC (pregnant cell added) 
Percent suppression =  PFC (control cells added)  X  100. 
§ The residual cells were resuspended in a volume equal to that required to give 10  X  t06/m| for the ceils 
with no anti-Thy 1.2 treatment, and  1 ml of cell suspension added to the control cultures. 
II 3  x  106 cells of macrophage population added to the normal cultures. 904  IMMUNE  RESPONSES  DURING PREGNANCY 
TABLE VI 
Secretion of Soluble Suppressive Factor(s) In Vitro 
PFC/culture _  SE 
Group  Cells in culture  Source of supernate* 
Exp. 1  Exp. 2 
A  Normal spleen  Fresh medium  3,054 +  284  4,508 ±  262 
B  Normal spleen  Normal cell culture  2,208 ±  207  4,048 ±  248 
C  Normal spleen  Pregnant cell culture  973 ±  73 (56)  2,162 ±  207 (47) 
Figures in parentheses indicate percentage suppression compared to the control of PFC response (group 
B). 
* Supernates were obtained from 4-d cultures of normal or pregnant spleen cells (10 ×  106/ml) and 1 ml 
of the supernate added to the inner compartment of a Marbrook chamber. 
the  addition of  10  ×  106  cells of the  B-cell-enriched macrophage-depleted fraction 
suppressed the PFC responses of normal spleen cells. In another experiment, splenic 
macrophages were obtained from pregnant and control mice, as outlined in Materials 
and  Methods, and 3  X  106 cells of the macrophage-enriched population was added 
to the normal spleen cell cultures. Considering that  ~8-10% of pregnant  spleen ceils 
are latex-phagocytizing cells, it was calculated from the data on suppression by whole 
spleen cells that the addition of 3  ×  106 cells of the macrophage-enriched population 
should  provide sufficient ceils for suppression.  However, the results show that  there 
was  no suppression by the pregnant  macrophage population;  the PFC response was 
about the same as those where the same numbers of cells from the control macrophage 
population were added (Table V, exp. F). 
Suppression  of PFC Responses  by the Culture Supernate.  To  determine whether or not 
pregnant  spleen cells produce  a  soluble suppressive  factor(s),  10  ×  106  spleen cells 
from ~  15-d pregnant and age-matched control mice were cultured in  1 ml of culture 
media  with  or  without  10  ×  106  SRBC  in  the  Linbro  Costar  fiat-bottom culture 
plates (Costar, Data Packaging, Cambridge, Mass.). 4 d later the supernatant medium 
was obtained and centrifuged at  2,000  rpm  for  10  min  to remove cells.  1 ml of the 
supernatant  medium  was added to the inner compartment  of a  Marbrook chamber 
containing 1 ml of the cell suspension (10  ×  10S/ml) of normal spleen cells. As shown 
in Table VI, the supernate of the control spleen cells showed a slightly decreased PFC 
response compared to the addition of fresh culture medium. However, the supernate 
of pregnant spleen cells was strikingly suppressive compared to that of control spleen 
cells  (P  <  0.05)  suggesting  the  secretion  of  a  soluble  suppressive  factor(s)  from 
pregnant  spleen  cells.  This  experiment  was  repeated  four  times  with  essentially 
identical results. Antigenic stimulations of pregnant  spleen cells with SRBC  did not 
appear to alter the production  of the factor(s), because the supernatant  medium  of 
the culture with SRBC  added suppressed to the same degree as that shown in Table 
VI. 
Discussion 
Several recent studies have suggested that suppressor cell activity may be involved 
in pregnancy-associated decreased immune  responses  (9, 20-22).  For example, Clark 
and MacDermott  (20) have presented evidence for the presence of a suppressor cell(s) 
for paternal antigens in the mixed lymphocyte cultures of the cells from the draining 
lymph nodes of the uterus, although the type of the suppressor cell(s) was not defined KOJI SUZUKI AND T.  B. TOMASI, Jr.  905 
in  this  study.  Adoptive  transfer  of spleen  cells  from  multiparous  mice  to  virgin 
recipients has also been reported to induce tolerance to the H-Y antigen in male skin 
graft and this appears to be mediated by suppressor T  cells (21). Similar suppressor 
T  cells have also been reported in humans  (22). In addition, it has been shown by 
Hamilton  and  Hellstr/Sm  (9)  that  the mixtures of lymphocytes from pregnant  and 
virgin  mice  are  less  reactive  to  alloantigen  stimulation  than  the  individual  cell 
population alone, suggesting the presence of nonspecific suppressor cells in pregnant 
mice. Our study has presented evidence for the involvement of suppressor cell activity 
in  the  decreased  splenic  antibody  responses  of pregnant  mice.  The  primary  IgM 
antibody synthesis against SRBC in vivo as well as in vitro are markedly decreased in 
the spleen cells of pregnant mice and this decrease of antibody synthesis is probably 
mediated via nonspecific suppressor cells.  This is evidenced by the observation that 
the addition of pregnant spleen cells to normal spleen cell cultures causes a significant 
suppression of PFC responses of normal spleen cells. Whether the diminished primary 
and secondary IgG and IgA splenic antibody responses of pregnant mice previously 
reported  from  this  laboratory  (7)  are  mediated  by  suppressor  cells  has  not  been 
explored. 
An  interesting observation is that the suppressor cell activity in pregnant mice is 
evident only in spleen cells and not in lymph node cells.  Similar observations of the 
preferential localization of suppressor cells in spleens rather than lymph nodes has 
been described in animals under conditions of tumor growth  (23, 24), graft vs. host 
(GVH)  reactions  (25), and certain bacterial infections, as well as in animals which 
have been immunized with a large dose of antigen (26, 27). It has been suggested that 
the  microenvironment  of the  spleen  may  be  favorable  to  the  generation  and/or 
trapping of suppressor cells (25). Gershon et al. (25) have described that under certain 
experimental  conditions  immune  responses  are  suppressed  by  a  subpopulation  of 
thymocytes and/or thymus-derived cells. These cells are short-lived Tx cells, contin- 
uously being replenished from the thymic cortex, preferentially homing to spleens, 
and  expressing suppressor cell activity there.  Perhaps  increased mobilization of Ta 
cells  from  thymus  to  spleen  may  take  place  during  pregnancy  resulting  in  the 
enrichment  of suppressor  cells  in  the  pregnant  spleen.  This  could  be  one  of the 
explanations for the concomitant manifestation of pregnancy-associated thymic atro- 
phy and spleen enlargement. As pointed out by Anderson (28), thymic atrophy and 
spleen  enlargement  similar  to  those  seen  during  pregnancy  also  occur  in  tumor- 
bearing animals in which spleen-seeking thymocytes have been postulated to operate 
in the immune suppression associated with certain tumors. 
We  have  demonstrated  that  at  least  two  cell  populations  are  involved  in  the 
decreased PFC responses of pregnant spleen cells. One is T  cells and the other is a 
nylon-wool-adherent cell present in the B-cell-enriched macrophage-depleted fraction. 
Suppression  by  T  cells  is  abolished  by  treatment  with  anti-Thy  1.2  serum  plus 
complement  while  such  treatment  does  not  alter  suppression  by  the  nylon-wool- 
adherent cells. This suggests that the nylon-wool-adherent suppressor cells are different 
from the nylon-wool-adherent T  suppressor cells described by Tada (29). The nylon- 
wool-adherent cells of pregnant mice are still suppressive after macrophages contained 
in this population are depleted. Thus, the nature of the suppressor cell(s) in the nylon- 
adherent preparations has not been defined, although because B cells represent the 
majority of cells remaining in the macrophage-depleted Thy 1.2-negative nylon-wool- 906  IMMUNE RESPONSES DURING PREGNANCY 
adherent fraction, suppression by pregnant spleen cells may be in part caused by the 
B-cell population. 
The mechanisms by which the two cell populations of pregnant spleens exert their 
suppressive activity are unknown. It is possible that these cells act via interaction with 
each other and/or  other types of cells.  For example, the  nylon-wool-adherent  sup- 
pressor cells of pregnant  mice could  affect the T  helper cells  in  a  T-B  interaction 
similar  to  that  described  in  GVH  mice  (30).  Alternatively,  pregnant  T  cells  may 
secrete soluble factors which in turn inhibit the response of B cells. Our preliminary 
data  suggests  that  the  suppressed  PFC  responses  of normal  spleen  cells  after  the 
addition  of pregnant  cells  may  be  mediated  via  a  soluble  factor(s)  released  from 
pregnant spleen cells. However, neither the cells producing the factor nor the target 
cells producing the factor(s) have as yet been defined. Although most of the suppressive 
factors contained in pregnant sera have been reported to be the products of the fetus 
or  the  placenta,  our data  suggest  the  possibility that  a  suppressive serum  factor(s) 
could be elaborated by suppressor cells in pregnant spleens. 
Previous studies  have yielded conflicting results regarding mitogen-induced  blas- 
togenesis of maternal lymphocytes. The data presented here on the responsiveness of 
pregnant  lymphocytes  to  mitogens  is  similar  to  that  by  Anderson  (28)  who  has 
demonstrated  that  there  was  little  difference between  pregnant  and  control  mice. 
Similarly, antigen-induced proliferation of lymph node cells, including those draining 
the  uterus,  are  not  depressed  in  pregnant  mice.  However, some  investigators  have 
claimed a  significantly decreased  response to mitogens in pregnant  mice (6).  These 
discrepancies could result from strain difference of mice, time of pregnancy at which 
the assay was performed, and the in vitro culture conditions. We believe that a major 
problem in analyzing the effect of mouse sera on immune reactions is the significant 
variation in suppressive potency of various pools of normal and pregnant sera. It is 
essential, therefore, to compare multiple pools of pregnant sera with several pools of 
age-matched nonpregnant  female controls. We also emphasize that the present data 
has been obtained at one point during pregnancy (~ 15 d) and that studies at different 
times  are  necessary.  However,  we  have  observed  suppression  in  the  primary and 
secondary splenic  PFC  response between  10  and  20  d  of pregnancy  (7),  suggesting 
that similar factors may operate during this time span. 
Summary 
The primary IgM antibody response to sheep erythrocytes in vivo as well as in vitro 
is markedly decreased in the spleen cells of pregnant mice, compared to age-matched 
female controls. Decreased antibody synthesis appears to be mediated by nonspecific 
suppressor cells, because the addition  of pregnant  spleen cells to the normal spleen 
cell cultures causes a  significant suppression of plaque-forming-cell responses of the 
normal  spleen  cells.  Suppressor  cell  activity  was  not  observed  in  lymph  nodes  of 
pregnant mice. At least two populations of pregnant spleen cells were shown to exert 
a  suppressor cell activity; one is T  lymphocytes and the other a  nylon-adherent cell 
present  in  the  B-cell-enriched  macrophage-depleted  fraction.  Pregnant  spleen  ceils 
cultured  in  vitro  were  shown  to  secrete  a  soluble  suppressive  factor(s)  into  the 
supernatant medium. KOJI  SUZUKI AND T,  B.  TOMASI, Jr.  907 
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